Mechanisms of Yin Yang 1 in oncogenesis: the importance of indirect effects.

Yin Yang 1 (YY1) is a ubiquitously expressed transcription factor that performs numerous functions including transcriptional regulation, cell growth control, apoptosis, large-scale chromosomal dynamics, and X-chromosome inactivation. YY1 clearly is able to control cell functions, including proliferation, by acting as a transcription factor either to activate or repress specific genes. Based on its ability to regulate cell growth control genes, it has been argued that YY1 can function as an oncogene that initiates oncogenesis. Although this is an attractive hypothesis, no reports indicate that YY1 can acutely transform cells in culture or form tumors within animals when overexpressed. Thus, it remains unclear whether YY1 is a "classic" oncogene. However, YY1 controls many diverse cell functions, and these functions may provide clues to its role in oncogenesis. We propose that in many cases YY1 may function in oncogenesis and disease progression through "indirect" effects by virtue of its role in either recruiting Polycomb group proteins to DNA, regulating mutator protein accumulation, controlling large-scale chromosomal dynamics or genomic integrity. Disruption of these functions may causally initiate cancer or may contribute to disease progression. Targeting YY1 functions provides possible avenues for clinical intervention.

[1]  Yang Shi,et al.  Endoplasmic Reticulum Stress Induction of the Grp78/BiP Promoter: Activating Mechanisms Mediated by YY1 and Its Interactive Chromatin Modifiers , 2005, Molecular and Cellular Biology.

[2]  L. Bystrykh,et al.  The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion. , 2006, Blood.

[3]  M. Vidal,et al.  Homeotic transformations of the axial skeleton of YY1 mutant mice and genetic interaction with the Polycomb group gene Ring1/Ring1A , 2006, Mechanisms of Development.

[4]  Zhiping Weng,et al.  Analysis of overrepresented motifs in human core promoters reveals dual regulatory roles of YY1. , 2007, Genome research.

[5]  S. Nishiguchi,et al.  Polycomb Group Gene rae28 Is Required for Sustaining Activity of Hematopoietic Stem Cells , 2002, The Journal of experimental medicine.

[6]  M. Atchison,et al.  Transient requirements of YY1 expression for PcG transcriptional repression and phenotypic rescue , 2005, Journal of cellular biochemistry.

[7]  M. Atchison,et al.  Characterization of Functional Domains within the Multifunctional Transcription Factor, YY1 (*) , 1995, The Journal of Biological Chemistry.

[8]  Qiang Yu,et al.  Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. , 2007, Genes & development.

[9]  J. Radford,et al.  YY1 expression predicts favourable outcome in follicular lymphoma , 2010, Journal of Clinical Pathology.

[10]  A. Birve,et al.  A 1-Megadalton ESC/E(Z) Complex from Drosophila That Contains Polycomblike and RPD3 , 2003, Molecular and Cellular Biology.

[11]  S. Yonehara,et al.  A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor , 1989, The Journal of experimental medicine.

[12]  J. Girton,et al.  Novel embryonic and adult homeotic phenotypes are produced by pleiohomeotic mutations in Drosophila. , 1994, Developmental biology.

[13]  G. Stein,et al.  Targeting of the YY1 transcription factor to the nucleolus and the nuclear matrix in situ: The C‐terminus is a principal determinant for nuclear trafficking , 1998, Journal of cellular biochemistry.

[14]  Y. Shi,et al.  Multiple mechanisms of transcriptional repression by YY1 , 1997, Molecular and cellular biology.

[15]  Isora V Sernandez,et al.  Haploinsufficiency of Activation-Induced Deaminase for Antibody Diversification and Chromosome Translocations both In Vitro and In Vivo , 2008, PloS one.

[16]  Reiko Shinkura,et al.  Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1 , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Wen‐Ming Yang,et al.  Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  T. Kajiume,et al.  Polycomb group gene mel-18 modulates the self-renewal activity and cell cycle status of hematopoietic stem cells. , 2004, Experimental hematology.

[19]  M. Atchison,et al.  PcG recruitment by the YY1 REPO domain can be mediated by Yaf2 , 2009, Journal of cellular biochemistry.

[20]  P. Hokland,et al.  Gene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia , 2008, European journal of haematology.

[21]  V. Pirrotta,et al.  Drosophila Enhancer of Zeste/ESC Complexes Have a Histone H3 Methyltransferase Activity that Marks Chromosomal Polycomb Sites , 2002, Cell.

[22]  A. Otte,et al.  Polycomb group protein complexes: do different complexes regulate distinct target genes? , 1999, Biochimica et biophysica acta.

[23]  C. Meijer,et al.  Polycomb-group genes as regulators of mammalian lymphopoiesis. , 2001, Trends in immunology.

[24]  M. Lohuizen Functional analysis of mouse Polycomb group genes , 1998, Cellular and Molecular Life Sciences CMLS.

[25]  G. Castellano,et al.  Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression , 2010, Cell cycle.

[26]  Jeannie T. Lee,et al.  YY1 Tethers Xist RNA to the Inactive X Nucleation Center , 2011, Cell.

[27]  Kristian Helin,et al.  The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. , 2007, Genes & development.

[28]  G. Lyons,et al.  The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. , 2004, Genes & development.

[29]  R. DePinho,et al.  The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus , 1999, Nature.

[30]  M. Murvai,et al.  Transcriptional activity of human papillomavirus type 16 variants having deletions in the long control region. , 2001, European journal of cancer.

[31]  S. Saleque,et al.  Yin Yang 1 Is a Lipopolysaccharide-Inducible Activator of the Murine 3′ Igh Enhancer, hs3 1 , 2003, The Journal of Immunology.

[32]  M. van Lohuizen,et al.  Polycomb repression: from cellular memory to cellular proliferation and cancer. , 2002, Biochimica et biophysica acta.

[33]  M. West,et al.  Patterns of Gene Expression That Characterize Long-term Survival in Advanced Stage Serous Ovarian Cancers , 2005, Clinical Cancer Research.

[34]  E. Hurt,et al.  Clinical significance of Polycomb gene expression in brain tumors , 2010, Molecular Cancer.

[35]  T. Honjo,et al.  Specific Expression of Activation-induced Cytidine Deaminase (AID), a Novel Member of the RNA-editing Deaminase Family in Germinal Center B Cells* , 1999, The Journal of Biological Chemistry.

[36]  D. Ghosh,et al.  A polycomb repression signature in metastatic prostate cancer predicts cancer outcome. , 2007, Cancer research.

[37]  M. Atchison,et al.  Identification of YY1 sequences necessary for association with the nuclear matrix and for transcriptional repression functions , 1998, Journal of cellular biochemistry.

[38]  C. Pilarsky,et al.  Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. , 2004, Neoplasia.

[39]  David Jung,et al.  Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. , 2006, Annual review of immunology.

[40]  Hengbin Wang,et al.  Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing , 2002, Science.

[41]  K. Calame,et al.  Yin-yang 1 activates the c-myc promoter , 1993, Molecular and cellular biology.

[42]  A. Iwama,et al.  Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. , 2004, Immunity.

[43]  E. Moran,et al.  Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. , 1995, Genes & development.

[44]  M. Bucan,et al.  Promoter features related to tissue specificity as measured by Shannon entropy , 2005, Genome Biology.

[45]  P. Möller,et al.  Monoclonal antibody-mediated tumor regression by induction of apoptosis. , 1989, Science.

[46]  Matthew D. Smith,et al.  p53 binds to and is required for the repression of Arf tumor suppressor by HDAC and polycomb. , 2011, Cancer research.

[47]  H. Mano,et al.  Overexpression of enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy , 2011, Haematologica.

[48]  K. Oestreich,et al.  Accessibility control of V(D)J recombination. , 2006, Advances in immunology.

[49]  F. Stubenrauch,et al.  The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. , 1994, The EMBO journal.

[50]  F. Karch,et al.  A conserved sequence motif in Polycomb-response elements. , 1998, Molecular cell.

[51]  C. Andry,et al.  Transcription factor YY1 expression in human gastrointestinal cancer cells. , 2009, International journal of oncology.

[52]  Tapio Visakorpi,et al.  The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late‐stage prostate cancer , 2006, Genes, chromosomes & cancer.

[53]  M. Majidi,et al.  Differential expression of the human ST5 gene in HeLa-fibroblast hybrid cell lines mediated by YY1: evidence that YY1 plays a part in tumor suppression. , 1996, Nucleic acids research.

[54]  N. Bonini,et al.  Transcription factor YY1 functions as a PcG protein in vivo , 2003, The EMBO journal.

[55]  D. Reinberg,et al.  Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. , 2004, Genes & development.

[56]  Alberto Martin,et al.  AID and mismatch repair in antibody diversification , 2002, Nature Reviews Immunology.

[57]  E. Seto,et al.  Molecular Cloning and Functional Characterization of the Transcription Factor YY2* , 2004, Journal of Biological Chemistry.

[58]  E. Jane,et al.  The Drosophila Polycomb Group proteins ESC and E(Z) are present in a complex containing the histone-binding protein p55 and the histone deacetylase RPD3. , 2001, Development.

[59]  C. Croce,et al.  miR-181b negatively regulates activation-induced cytidine deaminase in B cells , 2008, The Journal of experimental medicine.

[60]  B. Bonavida,et al.  Involvement of the TNF-α autocrine–paracrine loop, via NF-κB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis , 2006 .

[61]  J. Lear,et al.  Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. , 1996, Cancer research.

[62]  M. Whiteley,et al.  The Drosophila Polycomb group gene pleiohomeotic encodes a DNA binding protein with homology to the transcription factor YY1. , 1998, Molecular cell.

[63]  M. Atchison,et al.  YY1 DNA binding and PcG recruitment requires CtBP. , 2004, Genes & development.

[64]  M. Atchison,et al.  Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[65]  F. Stubenrauch,et al.  Prevalence of deletions of YY1‐binding sites in episomal HPV 16 DNA from cervical cancers , 1994, International journal of cancer.

[66]  D. Spandidos,et al.  Yin Yang 1 expression in human tumors , 2010, Cell cycle.

[67]  U. Thorsteinsdóttir,et al.  Functional antagonism of the Polycomb-Group genes eed and Bmi1 in hemopoietic cell proliferation. , 1999, Genes & development.

[68]  L. Stubbs,et al.  YY1 as a controlling factor for the Peg3 and Gnas imprinted domains. , 2007, Genomics.

[69]  Vasco M. Barreto,et al.  Somatic Hypermutation Is Limited by CRM1-dependent Nuclear Export of Activation-induced Deaminase , 2004, The Journal of experimental medicine.

[70]  G. Sauvageau,et al.  Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells , 2003, Nature.

[71]  D. Reinberg,et al.  Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. , 2002, Genes & development.

[72]  M. Lohuizen,et al.  Stem Cells and Cancer The Polycomb Connection , 2004, Cell.

[73]  Anton Berns,et al.  Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging , 1991, Cell.

[74]  Yang Shi,et al.  Transcriptional repression by YY1, a human GLI-Krüippel-related protein, and relief of repression by adenovirus E1A protein , 1991, Cell.

[75]  Yan-wei Lin,et al.  Gene Silencing by the Polycomb Group Proteins and Associations With Cancer , 2011, Cancer investigation.

[76]  Michael R. Green,et al.  Inappropriate Gene Activation in FSHD A Repressor Complex Binds a Chromosomal Repeat Deleted in Dystrophic Muscle , 2002, Cell.

[77]  V. Pirrotta,et al.  Chromatin-silencing mechanisms in Drosophila maintain patterns of gene expression. , 1997, Trends in genetics : TIG.

[78]  Yang Shi,et al.  A YY1–INO80 complex regulates genomic stability through homologous recombination–based repair , 2007, Nature Structural &Molecular Biology.

[79]  S. Dhanasekaran,et al.  The polycomb group protein EZH2 is involved in progression of prostate cancer , 2002, Nature.

[80]  A. Gozdzicka-Jozefiak,et al.  Intratype HPV16 sequence variation within LCR of isolates from asymptomatic carriers and cervical cancers. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[81]  C. Napoli,et al.  Cooperation between Myc and YY1 provides novel silencing transcriptional targets of α3β1-integrin in tumour cells , 2007, Oncogene.

[82]  Kristian Helin,et al.  EZH2 is downstream of the pRB‐E2F pathway, essential for proliferation and amplified in cancer , 2003, The EMBO journal.

[83]  Michel C Nussenzweig,et al.  MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. , 2008, Immunity.

[84]  C. Cerni,et al.  YY1 can inhibit c-Myc function through a mechanism requiring DNA binding of YY1 but neither its transactivation domain nor direct interaction with c-Myc , 1998, Oncogene.

[85]  D. Margolis,et al.  Targeted Derepression of the Human Immunodeficiency Virus Type 1 Long Terminal Repeat by Pyrrole-Imidazole Polyamides , 2002, Journal of Virology.

[86]  Yang Shi,et al.  Essential Dosage-Dependent Functions of the Transcription Factor Yin Yang 1 in Late Embryonic Development and Cell Cycle Progression , 2006, Molecular and Cellular Biology.

[87]  D. Schatz,et al.  The RAG proteins and V(D)J recombination: complexes, ends, and transposition. , 2000, Annual review of immunology.

[88]  Hui Wang,et al.  RYBP stabilizes p53 by modulating MDM2 , 2009, EMBO reports.

[89]  C. Napoli,et al.  Deletion of Yin Yang 1 protein in osteosarcoma cells on cell invasion and CXCR4/angiogenesis and metastasis. , 2008, Cancer research.

[90]  E. Seto,et al.  Adenovirus E1A proteins interact with the cellular YY1 transcription factor , 1995, Journal of virology.

[91]  T. Honjo,et al.  Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme , 2000, Cell.

[92]  B. Bonavida,et al.  Rituximab-Induced Inhibition of YY1 and Bcl-xL Expression in Ramos Non-Hodgkin’s Lymphoma Cell Line via Inhibition of NF-κB Activity: Role of YY1 and Bcl-xL in Fas Resistance and Chemoresistance, Respectively1 , 2005, The Journal of Immunology.

[93]  Bernhard Lüscher,et al.  Characterization of the Transcriptional Regulator YY1 , 1997, The Journal of Biological Chemistry.

[94]  J. Min,et al.  Structural basis for specific binding of Polycomb chromodomain to histone H3 methylated at Lys 27. , 2003, Genes & development.

[95]  J. Simon,et al.  Roles of the EZH2 histone methyltransferase in cancer epigenetics. , 2008, Mutation research.

[96]  S. Grossman,et al.  Yin Yang 1 Is a Negative Regulator of p53 , 2004, Cell.

[97]  Debashis Ghosh,et al.  EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[98]  Guangchao Sui,et al.  The Regulation of YY1 in Tumorigenesis and its Targeting Potential in Cancer Therapy , 2009 .

[99]  A. Otte,et al.  Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation , 1999, Nature Genetics.

[100]  R. Hoffman,et al.  Essential Role for Activation of the Polycomb Group (PcG) Protein Chromatin Silencing Pathway in Metastatic Prostate Cancer , 2006, Cell cycle.

[101]  Techung Lee,et al.  Proteolytic Regulation of the Zinc Finger Transcription Factor YY1, a Repressor of Muscle-restricted Gene Expression* , 1998, The Journal of Biological Chemistry.

[102]  Yang Shi,et al.  Targeted Disruption of Mouse Yin Yang 1 Transcription Factor Results in Peri-Implantation Lethality , 1999, Molecular and Cellular Biology.

[103]  C. Napoli,et al.  Expression of transcription factor Yin Yang 1 in human osteosarcomas. , 2006, European journal of cancer.

[104]  E. Seto,et al.  Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? , 1999, Gene.

[105]  B Z Levi,et al.  Cloning of a negative transcription factor that binds to the upstream conserved region of Moloney murine leukemia virus , 1992, Molecular and cellular biology.

[106]  B. Bonavida,et al.  Transcription factor YY1: structure, function, and therapeutic implications in cancer biology , 2006, Oncogene.

[107]  D. Schatz,et al.  Balancing AID and DNA repair during somatic hypermutation. , 2009, Trends in immunology.

[108]  M. Lohuizen The trithorax-group and polycomb-group chromatin modifiers: implications for disease. , 1999 .

[109]  T. Magnuson,et al.  Murine Polycomb- and trithorax-group genes regulate homeotic pathways and beyond. , 1997, Trends in genetics : TIG.

[110]  M. Lieber,et al.  The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia. , 2009, Cancer cell.

[111]  K. Rajewsky,et al.  Yin Yang 1 is a critical regulator of B-cell development. , 2007, Genes & development.

[112]  Y. Shi,et al.  Transcription factor Yin Yang 1 stimulates poly(ADP-ribosyl)ation and DNA repair. , 2001, Biochemical and biophysical research communications.

[113]  M. Moriuchi,et al.  YY1 Transcription Factor Down-regulates Expression of CCR5, a Major Coreceptor for HIV-1* , 2003, The Journal of Biological Chemistry.

[114]  S. Horvath,et al.  Expression of transcription factor Yin Yang 1 in prostate cancer. , 2005, International journal of oncology.

[115]  V. Pirrotta,et al.  PcG complexes and chromatin silencing. , 1997, Current opinion in genetics & development.

[116]  E. Jennings,et al.  DNA binding sites for the transcriptional activator/repressor YY1. , 1995, Nucleic acids research.

[117]  L. Pasqualucci,et al.  AID is required for germinal center–derived lymphomagenesis , 2008, Nature Genetics.

[118]  G. Peters,et al.  Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all , 2006, Nature Reviews Molecular Cell Biology.

[119]  Thomas Tuschl,et al.  MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. , 2008, Immunity.

[120]  K. Calame,et al.  An analysis of genes regulated by the multi-functional transcriptional regulator Yin Yang-1. , 1994, Nucleic acids research.

[121]  P. Kang,et al.  Interaction between YY1 and the Retinoblastoma Protein , 2001, The Journal of Biological Chemistry.

[122]  I. Ovcharenko,et al.  Identification of clustered YY1 binding sites in imprinting control regions. , 2006, Genome research.

[123]  Youngchang Kim,et al.  Molecular basis for the discrimination of repressive methyl-lysine marks in histone H3 by Polycomb and HP1 chromodomains. , 2003, Genes & development.

[124]  K Kornfeld,et al.  Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. , 1999, Genes & development.

[125]  D. Margolis,et al.  Counterregulation of Chromatin Deacetylation and Histone Deacetylase Occupancy at the Integrated Promoter of Human Immunodeficiency Virus Type 1 (HIV-1) by the HIV-1 Repressor YY1 and HIV-1 Activator Tat , 2002, Molecular and Cellular Biology.

[126]  M. Busslinger,et al.  Locus 'decontraction' and centromeric recruitment contribute to allelic exclusion of the immunoglobulin heavy-chain gene , 2005, Nature Immunology.

[127]  Jeffrey T. Chang,et al.  Yin Yang 1 Modulates Taxane Response in Epithelial Ovarian Cancer , 2009, Molecular Cancer Research.

[128]  L. Stubbs,et al.  Rapid evolution of a recently retroposed transcription factor YY2 in mammalian genomes. , 2006, Genomics.

[129]  Jeremy J. W. Chen,et al.  The transcriptional factor YY1 upregulates the novel invasion suppressor HLJ1 expression and inhibits cancer cell invasion , 2005, Oncogene.

[130]  T. Lee,et al.  Bifunctional transcriptional properties of YY1 in regulating muscle actin and c-myc gene expression during myogenesis. , 1994, Oncogene.

[131]  Roy Riblet,et al.  Visualization of looping involving the immunoglobulin heavy-chain locus in developing B cells. , 2005, Genes & development.

[132]  M. Atchison,et al.  Polycomb recruitment to DNA in vivo by the YY1 REPO domain , 2006, Proceedings of the National Academy of Sciences.

[133]  Brigitte Wild,et al.  Histone Methyltransferase Activity of a Drosophila Polycomb Group Repressor Complex , 2002, Cell.

[134]  Jeannie T. Lee,et al.  Identification of a Ctcf cofactor, Yy1, for the X chromosome binary switch. , 2007, Molecular cell.

[135]  D. Margolis,et al.  Human transcription factor YY1 represses human immunodeficiency virus type 1 transcription and virion production , 1994, Journal of virology.

[136]  Y. Nakanuma,et al.  The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma , 2008, Laboratory Investigation.

[137]  B. Bonavida,et al.  Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis , 2005, Oncogene.

[138]  J. Shaughnessy,et al.  Leukaemia disease genes: large-scale cloning and pathway predictions , 1999, Nature Genetics.

[139]  Thomas Shenk,et al.  TATA-binding protein-independent initiation: YY1, TFIIB, and RNA polymerase II direct basal transcription on supercoiled template DNA , 1994, Cell.

[140]  O. Halvorsen,et al.  EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[141]  M. Watson,et al.  Activation-induced Cytosine Deaminase (AID) Is Actively Exported out of the Nucleus but Retained by the Induction of DNA Breaks* , 2004, Journal of Biological Chemistry.

[142]  J. Nevins,et al.  Interaction of YY1 with E2Fs, mediated by RYBP, provides a mechanism for specificity of E2F function , 2002, The EMBO journal.

[143]  S. Morrison,et al.  Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation , 2003, Nature.

[144]  H. Bernard,et al.  A transcriptional initiator overlaps with a conserved YY1 binding site in the long control region of human papillomavirus type 16. , 2003, Virology.

[145]  C. Milstein,et al.  AID-GFP chimeric protein increases hypermutation of Ig genes with no evidence of nuclear localization , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[146]  T. Honjo,et al.  Role of AID in tumorigenesis. , 2007, Advances in immunology.

[147]  B. Bonavida,et al.  Nitric Oxide Inhibits the Transcription Repressor Yin-Yang 1 Binding Activity at the Silencer Region of the Fas Promoter: A Pivotal Role for Nitric Oxide in the Up-Regulation of Fas Gene Expression in Human Tumor Cells1 , 2001, The Journal of Immunology.

[148]  Ruud Delwel,et al.  The gene encoding the transcriptional regulator Yin Yang 1 (YY1) is a myeloid transforming gene interfering with neutrophilic differentiation. , 2003, Blood.

[149]  Ya-Li Yao,et al.  Regulation of Transcription Factor YY1 by Acetylation and Deacetylation , 2001, Molecular and Cellular Biology.